TB Vax ARM: What's next for TB R&D post-HLM? A pre-Union virtual meeting
In preparation for the Union World Conference on Lung Health in Paris, France on 15-18 November 2023, the TB Vaccine Advocacy Roadmap (TB Vax ARM) will host a virtual meeting on 2 November 2023 exploring what’s next for TB research and development (R&D) following the United Nations High-Level Meeting on TB (HLM).
Featuring an update on the 2023 Pipeline Report on TB Vaccines from Mike Frick at Treatment Action Group, a rundown of TB vaccine highlights at the Union Conference, and hear from colleagues at Results Canada, RESULTS UK, Global Health Advocates, Stop TB Partnership, and Stop TB Indonesia followed by a short Q&A.
Register for the meeting here.
Learn more
The
TB Vax ARM
is a global coalition of TB stakeholders, including TB
survivors, civil society organizations, and non-profits,
invested in TB vaccine advocacy and research, and seeks to
provide coordinated advocacy efforts that are complementary to
ongoing TB vaccine R&D and policy efforts. The TB Vax ARM
holds regular advocacy meetings with partners from across the
world.
